NCR1 and cancer: Considering the increased expression of ecto‐CRT on cancer cells that we identified, NK cells may also participate through the NKp46‐ecto‐CRT axis.[74, 75] Although our T‐cell proliferation assays showed that enhanced phagocytosis by combo treatment did not expand T cells population (data not show), macrophages can serve as antigen‐presenting cells (APCs) post‐phagocytosis,[76] potentially promoting other antigen‐specific T‐cell responses.[77] Therefore, our study still lays the foundation for the subsequent involvement of adaptive immune response in immune‐competent mouse model.